Patents-Review.com
🔗 Permalink
Assignee profile:

PhaseRx, Inc.

City:

Seattle, Washington

Country:

United States

Published Applications:

21

Last publication date:

2017-08-24

Patent Grants:

14

Last grant date:

2019-09-24

Top Inventors for applications by PhaseRx, Inc.

These are the the leading inventors for applications assigned to PhaseRx, Inc.:

Recent patent applications by PhaseRx, Inc.

PhaseRx, Inc. based in Seattle, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2017-08-24 ✅ Patent 10,420,790 granted on 2019-09-24
US20170239360A1
Human necessities

Micellic assemblies

 #2 | 2017-05-25 ✅ Patent 10,066,043 granted on 2018-09-04
US20170145141A1
Chemistry; metallurgy

ω-functionalized polymers, junction-functionalized block copolymers, polymer bioconjugates, and radical chain extension polymerization

 #3 | 2017-04-06 ✅ Patent 9,862,792 granted on 2018-01-09
US20170096517A1
Chemistry; metallurgy

Diblock copolymers and polynucleotide complexes thereof for delivery into cells

 #4 | 2017-02-23
US20170049801A1
Human necessities

MULTIBLOCK COPOLYMERS

 #5 | 2016-09-01 ✅ Patent 9,662,403 granted on 2017-05-30
US20160250338A1
Human necessities

Micellic assemblies

 #6 | 2016-07-21 ✅ Patent 9,867,885 granted on 2018-01-16
US20160206750A1
Human necessities

Block copolymers

 #7 | 2016-03-24
US20160082121A1
Human necessities

BISPECIFIC INTRACELLULAR DELIVERY VEHICLES

 #8 | 2015-10-15
US20150291956A1
Chemistry; metallurgy

RNA TARGETED TO BETA CATENIN

 #9 | 2015-08-27
US20150238619A1
Human necessities

POLYMERIC CARRIER

 #10 | 2014-08-14 ✅ Patent 9,220,791 granted on 2015-12-29
US20140228516A1
Human necessities

Bispecific intracellular delivery vehicles

 #11 | 2013-01-10 ✅ Patent 9,415,113 granted on 2016-08-16
US20130011362A1
Human necessities

Targeting monomers and polymers having targeting blocks

 #12 | 2012-01-26 ✅ Patent 9,211,250 granted on 2015-12-15
US20120021514A1
Human necessities

Heterogeneous polymeric micelles for intracellular delivery

 #13 | 2011-12-15 ✅ Patent 9,593,169 granted on 2017-03-14
US20110305660A1
Chemistry; metallurgy

Omega-functionalized polymers, junction-functionalized block copolymers, polymer bioconjugates, and radical chain extension polymerization

 #14 | 2011-11-24 ✅ Patent 9,464,300 granted on 2016-10-11
US20110286957A1
Human necessities

Multiblock copolymers

 #15 | 2011-11-17
US20110281934A1
Human necessities

MICELLES OF HYDROPHILICALLY SHIELDED MEMBRANE-DESTABILIZING COPOLYMERS

 #16 | 2011-11-17 ✅ Patent 8,822,213 granted on 2014-09-02
US20110281354A1
Human necessities

Bispecific intracellular delivery vehicles

 #17 | 2011-06-16 ✅ Patent 9,006,193 granted on 2015-04-14
US20110143435A1
Chemistry; metallurgy

Polymeric carrier

 #18 | 2011-06-16 ✅ Patent 9,476,063 granted on 2016-10-25
US20110143434A1
Chemistry; metallurgy

Diblock copolymers and polynucleotide complexes thereof for delivery into cells

 #19 | 2011-06-16
US20110142951A1
Human necessities

MICELLES FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS

 #20 | 2011-06-02
US20110129921A1
Chemistry; metallurgy

TARGETED POLYMER BIOCONJUGATES

 #21 | 2011-05-26 ✅ Patent 9,339,558 granted on 2016-05-17
US20110123636A1
Human necessities

Micellic assemblies

Also check out PhaseRx, Inc.'s (Seattle, United States) applicant profile with 5 patent applications submitted.

AssigneeID:

3312 ⎘